Chemoinformaics analysis of D-ALANYL-GLYCINE
| Molecular Weight | 182.607 | nRot | 3 |
| Heavy Atom Molecular Weight | 171.519 | nRig | 2 |
| Exact Molecular Weight | 182.046 | nRing | 0 |
| Solubility: LogS | -0.194 | nHRing | 0 |
| Solubility: LogP | -2.766 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 22.4707 |
| nHD | 3 | BPOL | 13.2813 |
| QED | 0.453 |
| Synth | 2.42 |
| Natural Product Likeliness | -0.195 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.041 |
| HIA | 0.007 |
| CACO-2 | -6.233 |
| MDCK | 0.00427491 |
| BBB | 0.495 |
| PPB | 0.0824457 |
| VDSS | 0.284 |
| FU | 0.899069 |
| CYP1A2-inh | 0.007 |
| CYP1A2-sub | 0.034 |
| CYP2c19-inh | 0.054 |
| CYP2c19-sub | 0.054 |
| CYP2c9-inh | 0.037 |
| CYP2c9-sub | 0.111 |
| CYP2d6-inh | 0.015 |
| CYP2d6-sub | 0.184 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.026 |
| CL | 2.931 |
| T12 | 0.774 |
| hERG | 0.022 |
| Ames | 0.028 |
| ROA | 0.024 |
| SkinSen | 0.188 |
| Carcinogencity | 0.03 |
| EI | 0.072 |
| Respiratory | 0.139 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.934807 |